These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 6792414

  • 1. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
    Kovacs SA, Geekie KM, Oxenhandler RW, Agris PF.
    J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
    [Abstract] [Full Text] [Related]

  • 2. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB, Iman DS, Lunsford JB.
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [Abstract] [Full Text] [Related]

  • 3. Formation of melanin-tyrosinase complex and its possible significance as a model for control of melanin synthesis.
    Menon IA, Haberman HF.
    Acta Derm Venereol; 1978 Jan; 58(1):9-11. PubMed ID: 75646
    [Abstract] [Full Text] [Related]

  • 4. The role of adenosine 3',5'-cyclic monophosphate in the density-dependent regulation of growth and tyrosinase activity of B-16 melanoma cells.
    Wade DR, Burkart ME.
    J Cell Physiol; 1978 Mar; 94(3):265-73. PubMed ID: 202603
    [Abstract] [Full Text] [Related]

  • 5. [Investigation of tyrosinase activity and phospholipid composition in Harding-Passey melanoma microsomal fraction].
    Shtol'ko VN, Bogdanov GN, Vasil'eva LS, Burlakova EB.
    Biokhimiia; 1978 Jan; 43(1):121-6. PubMed ID: 414789
    [Abstract] [Full Text] [Related]

  • 6. [Structural factors and the DOPA oxidase activity of membrane-bound tyrosinase].
    Shtol'ko VN, Kol'tover VK, Il'in AV, Vasil'eva LS, Bogdanov GN.
    Dokl Akad Nauk SSSR; 1979 Jan; 244(4):1009-12. PubMed ID: 104854
    [No Abstract] [Full Text] [Related]

  • 7. [Isoenzymes of melanosomal tyrosinase isolated from transplanted hamster melanomas].
    Blagoeva PM, Ivanova TsIa.
    Biokhimiia; 1984 May; 49(5):804-6. PubMed ID: 6430355
    [Abstract] [Full Text] [Related]

  • 8. Solubilizing effect of Trition X-100 on melanosome tyrosinase in hamster pigmented melanoma.
    Blagoeva PM.
    Neoplasma; 1977 May; 24(3):291-4. PubMed ID: 408715
    [Abstract] [Full Text] [Related]

  • 9. Melanogenesis in human melanomas.
    Chen YM, Chavin W.
    Cancer Res; 1975 Mar; 35(3):606-12. PubMed ID: 803870
    [Abstract] [Full Text] [Related]

  • 10. Effect of triamcinolone acetonide on tyrosinase activity in a human melanoma cell line.
    DiSorbo DM, Harris NA, Nathanson L.
    Cancer Res; 1984 May; 44(5):1752-5. PubMed ID: 6424929
    [Abstract] [Full Text] [Related]

  • 11. Action of endogenous proteases on the distribution of tyrosinase isozymes in Harding-Passey mouse melanoma.
    Martinez JH, Solano F, Lozano JA.
    Cell Biochem Funct; 1989 Jan; 7(1):21-6. PubMed ID: 2502324
    [Abstract] [Full Text] [Related]

  • 12. [The effect of dinitrophenylation on the tyrosinase activity of extracts from human melanomas].
    Schwartze G.
    Dermatol Monatsschr; 1986 Jan; 172(8):498-500. PubMed ID: 3095156
    [No Abstract] [Full Text] [Related]

  • 13. The effect of polyamines on tyrosinase activity.
    Galindo JD, Martinez JH, Lopez-Ballester JA, Peñafiel R, Solano F, Lozano JA.
    Biochem Int; 1987 Dec; 15(6):1151-8. PubMed ID: 3125836
    [Abstract] [Full Text] [Related]

  • 14. Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.
    Dernałowicz-Malarczyk E, Kotłowska-Niećko I.
    Neoplasma; 1980 Dec; 27(4):345-53. PubMed ID: 6779209
    [Abstract] [Full Text] [Related]

  • 15. Melanogenuria as consequence of elevated tyrosinase activity in melanoma.
    Duchon J, Matous B, Pavel S.
    Acta Univ Carol Med Monogr; 1977 Dec; (78 Pt 2):139-44. PubMed ID: 97931
    [Abstract] [Full Text] [Related]

  • 16. Serum tyrosinase in malignant disease, its activity, and the electrophoretic patterns of the enzyme as carried by immunoglobulins'.
    Chen YM, Lim BT, Chavin W.
    Cancer Res; 1979 Sep; 39(9):3485-90. PubMed ID: 113092
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of tyrosinase by dihydroxy phenyl derivatives.
    Karg E, Rosengren E, Rorsman H.
    Acta Derm Venereol; 1989 Sep; 69(6):521-4. PubMed ID: 2575328
    [Abstract] [Full Text] [Related]

  • 18. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
    Imokawa G, Mishima Y.
    Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
    [Abstract] [Full Text] [Related]

  • 19. Multi-hormonal regulation of tyrosinase expression in B16/C3 melanoma cells in culture.
    Smith TJ, Kline EL.
    Prog Clin Biol Res; 1988 May; 262():241-55. PubMed ID: 3131777
    [No Abstract] [Full Text] [Related]

  • 20. Decay of hormone responsiveness in mouse melanoma cells in culture as a function of cell density.
    Fuller BB, Lebowitz J.
    J Cell Physiol; 1980 May; 103(2):279-87. PubMed ID: 6254996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.